Hospital for Special Surgery - Archive Salmon
Filter by year
2025
April
10,
2025
|
10:00 AM
America/New_York
A landmark clinical trial co-led by Hospital for Special Surgery (HSS) has found that blocking inflammation with the drug certolizumab significantly reduces the risk of serious adverse pregnancy outcomes in women with antiphospholipid syndrome …
Read more
2024
October
15,
2024
|
10:00 AM
America/New_York
SciRhom GmbH, a biotech startup co-founded by Hospital for Special Surgery (HSS), recently secured a 63 million euro (US$70 million) Series A financing round to support the clinical development of its novel drug candidate, SR-878. The round was …
Read more
August
01,
2024
|
10:26 AM
America/New_York
The Lancet Rheumatology featuring Jane E. Salmon, MD
Read more
June
13,
2024
|
10:00 AM
America/New_York
A study from physician-scientists at the Hospital for Special Surgery (HSS) points to a potential novel approach for treating autoimmune diseases like rheumatoid arthritis — preventing antibodies and immune cells from leaving the bloodstream and …
Read more
2023
November
13,
2023
|
17:05 PM
America/New_York
Investigators from the Antiphospholipid Syndrome Alliance for Clinical Trials and International Networking (APS ACTION) presented new research findings in antiphospholipid syndrome (APS) at the American College of Rheumatology (ACR) Convergence …
Read more
July
04,
2023
|
13:05 PM
America/New_York
Rheum Now featuring Mary K. Crow, MD, Jane E. Salmon, MD, Lisa R. Sammaritano, MD, Medha Barbhaiya, MD, MPH.
Read more
March
27,
2023
|
16:54 PM
America/New_York
Very Well Family featuring Jane E. Salmon, MD and Caroline Siegel, MD
Read more
January
26,
2023
|
15:28 PM
America/New_York
HSS Research Institute’s Jane E. Salmon, MD, is conducting a groundbreaking, interventional trial funded by the NIH and Lupus Foundation of America (LFA) to help patients with lupus and antiphospholipid syndrome (APS) (often seen in lupus patients) …
Read more
2022
November
04,
2022
|
15:19 PM
America/New_York
Healio Rheumatology featuring Jane E. Salmon, MD
Read more
June
02,
2022
|
10:00 AM
America/New_York
A study that includes researchers at Hospital for Special Surgery (HSS) underscores the importance of a multidisciplinary medical team to counsel and provide care for women with systemic lupus erythematosus, the most common form of lupus, who become …
Read more
April
21,
2022
|
12:04 PM
America/New_York
The Lupus Foundation of America featuring Jane E. Salmon, MD
Read more
March
24,
2022
|
18:05 PM
America/New_York
Lupus Research Alliance featuring Jane E. Salmon, MD
Read more
2021
March
31,
2021
|
15:14 PM
America/New_York
Lupus Foundation of America featuring Jane E. Salmon, MD
Read more
January
29,
2021
|
22:06 PM
America/New_York
Rheumatology Advisor “Rheum On Air" podcast featuring Jane E. Salmon, MD
Read more
2020
November
18,
2020
|
22:00 PM
America/New_York
The Rheumatologist featuring Jane E. Salmon, MD
Read more
September
18,
2020
|
08:00 AM
America/New_York
Thanks to the generous support of donors, Hospital for Special Surgery (HSS) has announced the funding of nine grants for projects related to the study of COVID-19. These projects reflect the institution’s expertise in basic, translational and …
Read more
August
05,
2020
|
21:22 PM
America/New_York
The Lupus Research Alliance featuring Jane E. Salmon, MD
Read more
March
27,
2020
|
12:53 PM
America/New_York
Rheumatology Advisor featuring Jane E. Salmon, MD
Read more
2019
December
19,
2019
|
08:00 AM
America/New_York
A successful phase III trial of anifrolumab in systemic lupus erythematosus (SLE), called TULIP-2 (Treatment of Uncontrolled Lupus via the Interferon Pathway–2), reported positive results in this week’s New England Journal of Medicine (NEJM).At …
Read more
September
01,
2019
|
16:07 PM
America/New_York
Weill Cornell Medicine featuring Jane E. Salmon, MD
Read more
April
08,
2019
|
10:55 AM
America/New_York
Women who have healthy pregnancies tend to show distinct changes in the activities of immune genes starting early in pregnancy, while women who have complicated pregnancies tend to show clear departures from that pattern, according to a new study …
Read more
January
15,
2019
|
07:00 AM
America/New_York
Can krill oil improve the quality of life of people living with systemic lupus erythematous? A clinical trial, involving 20 centers in the United States, is currently enrolling patients to answer this question. Hospital for Special Surgery (HSS), in …
Read more
2018
November
18,
2018
|
07:00 AM
America/New_York
The Rheumatologist reports on a new study that found that the incidence of lupus nephritis in patients with systemic lupus erythematosus (SLE) has decreased over the past 50 years. This retrospective study included 499 patients diagnosed with lupus …
Read more
October
18,
2018
|
07:00 AM
America/New_York
In an article by The Rheumatologist, Jane E. Salmon, MD, rheumatologist at HSS, addressed historical case studies by dermatologist Moriz Kaposi, MD, on systemic lupus erythematosus.
"Earlier physicians had done wonderful work and wrote eloquent …
Read more
August
29,
2018
|
07:00 AM
America/New_York
Lupus News Today reported that HSS rheumatologist Jane E. Salmon, MD, is launching a clinical trial to assess the benefits of fatty-rich krill oil in lupus patients.
"This trial reflects our responsiveness to patient wishes — a treatment that is …
Read more
July
06,
2018
|
07:00 AM
America/New_York
Mary K. Crow, MD, physician-in-chief and chief of Rheumatology, and Jane E. Salmon, MD, rheumatologist at Hospital for Special Surgery (HSS), have been named honorary members of the European League Against Rheumatism (EULAR) during the Annual …
Read more
April
03,
2018
|
07:00 AM
America/New_York
Rheumatology Advisor reporter Tori Rodriguez writes on using statins for cardiovascular risk reduction in rheumatoid arthritis patients.
She interviews Jane E. Salmon, MD, rheumatologist at HSS, who explains that statins have pleiotropic effects, …
Read more
April
03,
2018
|
07:00 AM
America/New_York
Healio Rheumatology reports on a recent HSS study, published in the Journal of Clinical Investigation, which found that inhibiting the inactive rhomboid 2 protein could help physicians prevent kidney injury in patients with systemic …
Read more
